Hormone receptor status and the role of oophorectomy in uterine leiomyosarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hormone receptor status and the role of oophorectomy in uterine leiomyosarcoma

Published:2022-12 Issue:3 Volume:167 Page:490-495
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Hinchcliff Emily,Rumpf Jennifer,Ratan Ravin,Fleming Nicole D.,Jazaeri Amir,Fellman Bryan,Meyer Larissa,Soliman Pamela

Funder

National Institutes of Health

National Cancer Institute

University of Texas MD Anderson Cancer Center

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference25 articles.

1. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy;Kapp;Cancer,2008

2. Prognosis and treatment of uterine leiomyosarcoma: a national cancer database study;Seagle;Gynecol. Oncol.,2017

3. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: results of a prospective study;Hensley;Gynecol. Oncol.,2009

4. Uterine sarcomas: a review;D’Angelo;Gynecol. Oncol.,2010

5. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer group study (protocol 55874);Reed;Eur. J. Cancer,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Treatment Options: Uterine Sarcoma;Current Treatment Options in Oncology;2024-05-31

2. Sarcoma incidence worldwide: regional differences in histology and molecular subtypes;Current Opinion in Oncology;2024-04-25

3. Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study;Medical Science Monitor;2023-11-10

4. Clinical Analysis and Prognostic Prediction Model for Patients with Uterine Leiomyosarcoma at FIGO Stage I;International Journal of Women's Health;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3